Parma, Italy

Blois-La Chaussée Saint Victor, France

Santana de Parnaíba, Brazil

Niefern, Germany

❮ ❯

Chiesi Farmaceutici has four production plants.

PARMA, ITALY

Our Parma plant is the strategic hub for the production and distribution of our products, serving as an international supply center with exports to over 80 countries.

Production capacity:

• 26 million packages in oral solids
• 13,5 million packs in Unit-Dose Vials  
• 42 million packs in Spray Inhalers  
• 6,5 million packs in Dry Powder Inhalers (DPI) 
• 1,400,000 vials in sterile suspensions
• >1 million packages of products for rare diseases and "Special care"

BLOIS-LA CHAUSSÉE SAINT VICTOR, FRANCE

The Blois plant is a center of excellence specializing in the production of Dry Powder Inhalers and Metered Dose Inhalers (MDIs). The site manages direct distribution to customers in the French market and exports to other markets, effectively meeting both local and international needs.

Production capacity:

• 9 million packages of Dry Powder Inhalers (DPI)
• 25 million packages of Metered-Dose Inhalers (MDI)

SANTANA DE PARNAÍBA, BRAZIL:

The plant in Brazil specializes in the production of pressurized solutions and suspensions for inhalation therapy (pMDIs), with a production capacity of 27 million units per year. Additionally, it has an area dedicated to nasal sprays for the European market, with a capacity of 13.5 million units per year.

Production Capacity:

• 70,1 million finished packages per year

NIEFERN, GERMANY:

Our plant in Niefern, Germany, specializes in the production of certain products for rare diseases. The site holds a production license and a GMP certificate for secondary packaging, testing, and release of sterile semi-solid medicinal products.